CLBS Annual Operating Profit
-$29.05 M
-$9.90 M-51.74%
31 December 2021
Summary:
As of February 5, 2025, CLBS annual operaing income is -$29.05 million, with the most recent change of -$9.90 million (-51.74%) on December 31, 2021. During the last 3 years, it has fallen by -$12.06 million (-71.01%).CLBS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Quarterly Operating Profit
-$37.72 M
-$31.00 M-461.31%
01 September 2022
Summary:
As of February 5, 2025, CLBS quarterly operating income is -$37.72 million, with the most recent change of -$31.00 million (-461.31%) on September 1, 2022. Over the past year, it has dropped by -$30.75 million (-441.33%).CLBS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS TTM Operating Profit
-$57.91 M
-$30.75 M-113.24%
01 September 2022
Summary:
As of February 5, 2025, CLBS TTM operating income is -$57.91 million, with the most recent change of -$30.75 million (-113.24%) on September 1, 2022. Over the past year, it has dropped by -$30.26 million (-109.46%).CLBS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBS Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -51.7% | -441.3% | -109.5% |
| 3 y3 years | -71.0% | -643.7% | -188.2% |
| 5 y5 years | -5.3% | -515.3% | -188.2% |
CLBS Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | >+9999.0% | >+9999.0% | >+9999.0% |
Caladrius Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$37.72 M(+461.3%) | -$57.91 M(+113.2%) |
| June 2022 | - | -$6.72 M(+1.5%) | -$27.16 M(-1.5%) |
| Mar 2022 | - | -$6.62 M(-3.3%) | -$27.58 M(-5.0%) |
| Dec 2021 | -$29.05 M(+51.7%) | -$6.85 M(-1.7%) | -$29.05 M(+5.1%) |
| Sept 2021 | - | -$6.97 M(-2.5%) | -$27.65 M(+6.2%) |
| June 2021 | - | -$7.15 M(-11.6%) | -$26.03 M(+12.3%) |
| Mar 2021 | - | -$8.09 M(+48.5%) | -$23.17 M(+21.0%) |
| Dec 2020 | -$19.14 M(-4.7%) | -$5.45 M(+1.8%) | -$19.14 M(+1.9%) |
| Sept 2020 | - | -$5.35 M(+24.7%) | -$18.78 M(+1.5%) |
| June 2020 | - | -$4.29 M(+5.8%) | -$18.50 M(-5.4%) |
| Mar 2020 | - | -$4.06 M(-20.2%) | -$19.56 M(-2.7%) |
| Dec 2019 | -$20.09 M(+18.3%) | -$5.08 M(+0.2%) | -$20.09 M(+6.8%) |
| Sept 2019 | - | -$5.07 M(-5.1%) | -$18.81 M(+7.5%) |
| June 2019 | - | -$5.35 M(+16.4%) | -$17.50 M(+6.6%) |
| Mar 2019 | - | -$4.59 M(+21.0%) | -$16.42 M(-3.3%) |
| Dec 2018 | -$16.99 M(-38.4%) | -$3.80 M(+0.9%) | -$16.99 M(-17.2%) |
| Sept 2018 | - | -$3.76 M(-11.9%) | -$20.51 M(-10.3%) |
| June 2018 | - | -$4.27 M(-17.3%) | -$22.88 M(-13.1%) |
| Mar 2018 | - | -$5.16 M(-29.5%) | -$26.32 M(-4.6%) |
| Dec 2017 | -$27.59 M(-6.5%) | -$7.32 M(+19.4%) | -$27.59 M(+7.1%) |
| Sept 2017 | - | -$6.13 M(-20.5%) | -$25.77 M(+1.6%) |
| June 2017 | - | -$7.71 M(+19.9%) | -$25.36 M(+1.2%) |
| Mar 2017 | - | -$6.43 M(+17.1%) | -$25.06 M(-15.6%) |
| Dec 2016 | -$29.50 M(-42.8%) | -$5.49 M(-4.1%) | -$29.70 M(-4.3%) |
| Sept 2016 | - | -$5.73 M(-22.7%) | -$31.04 M(-13.0%) |
| June 2016 | - | -$7.41 M(-33.1%) | -$35.70 M(-19.9%) |
| Mar 2016 | - | -$11.07 M(+62.0%) | -$44.56 M(-13.6%) |
| Dec 2015 | -$51.58 M(-10.7%) | -$6.84 M(-34.2%) | -$51.58 M(-14.5%) |
| Sept 2015 | - | -$10.38 M(-36.2%) | -$60.29 M(-8.9%) |
| June 2015 | - | -$16.27 M(-10.1%) | -$66.17 M(+6.2%) |
| Mar 2015 | - | -$18.09 M(+16.3%) | -$62.33 M(+7.9%) |
| Dec 2014 | -$57.74 M(+56.9%) | -$15.55 M(-4.3%) | -$57.74 M(+9.6%) |
| Sept 2014 | - | -$16.26 M(+30.8%) | -$52.68 M(+15.2%) |
| June 2014 | - | -$12.43 M(-7.9%) | -$45.74 M(+10.3%) |
| Mar 2014 | - | -$13.50 M(+28.6%) | -$41.48 M(+12.7%) |
| Dec 2013 | -$36.81 M(+21.1%) | -$10.49 M(+12.7%) | -$36.81 M(+7.4%) |
| Sept 2013 | - | -$9.31 M(+14.0%) | -$34.26 M(+3.7%) |
| June 2013 | - | -$8.17 M(-7.5%) | -$33.03 M(+4.3%) |
| Mar 2013 | - | -$8.83 M(+11.2%) | -$31.67 M(+4.2%) |
| Dec 2012 | -$30.39 M(-10.6%) | -$7.94 M(-1.8%) | -$30.39 M(+1.3%) |
| Sept 2012 | - | -$8.09 M(+18.8%) | -$30.00 M(+2.9%) |
| June 2012 | - | -$6.81 M(-9.7%) | -$29.14 M(-10.0%) |
| Mar 2012 | - | -$7.54 M(-0.2%) | -$32.37 M(+1.5%) |
| Dec 2011 | -$34.00 M(+85.6%) | -$7.56 M(+4.5%) | -$31.90 M(+3.5%) |
| Sept 2011 | - | -$7.23 M(-28.0%) | -$30.81 M(+5.1%) |
| June 2011 | - | -$10.04 M(+41.9%) | -$29.32 M(+28.7%) |
| Mar 2011 | - | -$7.08 M(+9.4%) | -$22.79 M(+24.4%) |
| Dec 2010 | -$18.32 M | -$6.47 M(+12.6%) | -$18.32 M(-23.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | -$5.74 M(+64.0%) | -$23.98 M(-5.8%) |
| June 2010 | - | -$3.50 M(+34.3%) | -$25.47 M(-4.5%) |
| Mar 2010 | - | -$2.61 M(-78.5%) | -$26.66 M(+2.9%) |
| Dec 2009 | -$25.87 M(+180.2%) | -$12.12 M(+67.7%) | -$25.91 M(+59.8%) |
| Sept 2009 | - | -$7.23 M(+53.9%) | -$16.22 M(+48.7%) |
| June 2009 | - | -$4.70 M(+153.1%) | -$10.91 M(+27.3%) |
| Mar 2009 | - | -$1.86 M(-23.6%) | -$8.57 M(-7.2%) |
| Dec 2008 | -$9.23 M(-11.5%) | -$2.43 M(+26.6%) | -$9.23 M(+1.0%) |
| Sept 2008 | - | -$1.92 M(-18.7%) | -$9.14 M(-20.8%) |
| June 2008 | - | -$2.36 M(-6.5%) | -$11.54 M(+3.6%) |
| Mar 2008 | - | -$2.52 M(+7.9%) | -$11.14 M(+6.8%) |
| Dec 2007 | -$10.44 M(+122.5%) | -$2.34 M(-45.9%) | -$10.44 M(+6.3%) |
| Sept 2007 | - | -$4.32 M(+120.9%) | -$9.81 M(+51.2%) |
| June 2007 | - | -$1.96 M(+7.6%) | -$6.49 M(+16.5%) |
| Mar 2007 | - | -$1.82 M(+5.9%) | -$5.57 M(+18.8%) |
| Dec 2006 | -$4.69 M(+193.0%) | -$1.72 M(+72.1%) | -$4.69 M(+35.4%) |
| Sept 2006 | - | -$998.00 K(-3.8%) | -$3.46 M(+15.2%) |
| June 2006 | - | -$1.04 M(+10.7%) | -$3.01 M(+29.3%) |
| Mar 2006 | - | -$937.40 K(+91.1%) | -$2.33 M(+45.3%) |
| Dec 2005 | -$1.60 M(+8.6%) | -$490.50 K(-9.5%) | -$1.60 M(+16.6%) |
| Sept 2005 | - | -$542.10 K(+52.3%) | -$1.37 M(+10.0%) |
| June 2005 | - | -$355.90 K(+67.6%) | -$1.25 M(-4.4%) |
| Mar 2005 | - | -$212.40 K(-19.1%) | -$1.31 M(-11.4%) |
| Dec 2004 | -$1.47 M(+64.9%) | -$262.60 K(-37.1%) | -$1.47 M(-6.8%) |
| Sept 2004 | - | -$417.40 K(+1.0%) | -$1.58 M(+16.2%) |
| June 2004 | - | -$413.30 K(+8.5%) | -$1.36 M(+18.1%) |
| Mar 2004 | - | -$381.00 K(+3.1%) | -$1.15 M(+28.8%) |
| Dec 2003 | -$894.30 K(-22.2%) | -$369.40 K(+87.7%) | -$894.40 K(+1.4%) |
| Sept 2003 | - | -$196.80 K(-3.9%) | -$882.10 K(-3.1%) |
| June 2003 | - | -$204.70 K(+65.7%) | -$910.30 K(+0.4%) |
| Mar 2003 | - | -$123.50 K(-65.4%) | -$906.50 K(-21.1%) |
| Dec 2002 | -$1.15 M(-28.4%) | -$357.10 K(+58.7%) | -$1.15 M(-7.4%) |
| Sept 2002 | - | -$225.00 K(+12.0%) | -$1.24 M(-11.5%) |
| June 2002 | - | -$200.90 K(-45.2%) | -$1.40 M(-9.8%) |
| Mar 2002 | - | -$366.30 K(-18.5%) | -$1.55 M(-0.8%) |
| Dec 2001 | -$1.61 M(-36.2%) | -$449.50 K(+16.6%) | -$1.57 M(-12.8%) |
| Sept 2001 | - | -$385.60 K(+9.3%) | -$1.80 M(-26.4%) |
| June 2001 | - | -$352.90 K(-6.7%) | -$2.44 M(-5.1%) |
| Mar 2001 | - | -$378.20 K(-44.3%) | -$2.57 M(+4.4%) |
| Dec 2000 | -$2.52 M(+146.1%) | -$679.40 K(-34.0%) | -$2.46 M(+38.1%) |
| Sept 2000 | - | -$1.03 M(+113.1%) | -$1.78 M(+136.9%) |
| June 2000 | - | -$483.10 K(+79.5%) | -$752.20 K(+179.5%) |
| Mar 2000 | - | -$269.10 K | -$269.10 K |
| Dec 1999 | -$1.02 M(+138.8%) | - | - |
| Dec 1998 | -$428.20 K(+93.2%) | - | - |
| Mar 1998 | -$221.60 K(-11.9%) | - | - |
| Mar 1997 | -$251.60 K(-2.1%) | - | - |
| Mar 1996 | -$257.10 K | - | - |
FAQ
- What is Caladrius Biosciences annual operaing income?
- What is the all time high annual operating profit for Caladrius Biosciences?
- What is Caladrius Biosciences annual operating profit year-on-year change?
- What is Caladrius Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Caladrius Biosciences?
- What is Caladrius Biosciences quarterly operating profit year-on-year change?
- What is Caladrius Biosciences TTM operating income?
- What is the all time high TTM operating profit for Caladrius Biosciences?
- What is Caladrius Biosciences TTM operating profit year-on-year change?
What is Caladrius Biosciences annual operaing income?
The current annual operating profit of CLBS is -$29.05 M
What is the all time high annual operating profit for Caladrius Biosciences?
Caladrius Biosciences all-time high annual operaing income is -$221.60 K
What is Caladrius Biosciences annual operating profit year-on-year change?
Over the past year, CLBS annual operaing income has changed by -$9.90 M (-51.74%)
What is Caladrius Biosciences quarterly operating income?
The current quarterly operating profit of CLBS is -$37.72 M
What is the all time high quarterly operating profit for Caladrius Biosciences?
Caladrius Biosciences all-time high quarterly operating income is -$123.50 K
What is Caladrius Biosciences quarterly operating profit year-on-year change?
Over the past year, CLBS quarterly operating income has changed by -$30.75 M (-441.33%)
What is Caladrius Biosciences TTM operating income?
The current TTM operating profit of CLBS is -$57.91 M
What is the all time high TTM operating profit for Caladrius Biosciences?
Caladrius Biosciences all-time high TTM operating income is -$269.10 K
What is Caladrius Biosciences TTM operating profit year-on-year change?
Over the past year, CLBS TTM operating income has changed by -$30.26 M (-109.46%)